Specific T-cell clones, identified in pre-screening for differential recognition of PRAME-positive vs. -negative cells, were analyzed using a broader tumor cell panel with multiple PRAME-negative or -positive tumor cell lines with varying levels of PRAME mRNA. This evidence concerns the gene PRAME and neoplasm.